Introduction
The identification of the agent(s) responsible for the phosphorylation of casein was one of the most teasing 'cold cases' of modern biochemistry. Although in fact casein was the first phosphoprotein ever detected, as early as in 1883 [1] and it was successfully exploited to detect and characterize in vitro several pleiotropic protein kinases (as documented by the acronyms CK1 and CK2 derived from the misnomers 'casein kinase' 1 and 2), the 'genuine' casein kinase remained an orphan enzyme for decades until its recent, unanticipated identification with Fam20C [2] [3] [4] , an atypical protein kinase, already known for being responsible for Raine syndrome, an often lethal osteosclorotic bone dysplasia first described in 1989 [5] .
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Exploiting a very selective peptide substrate, already before its identification with Fam20C, the genuine casein kinase, especially abundant in the Golgi apparatus of the lactating mammary gland, was shown to be present in the Golgi of other tissues as well (hence its acronym G-CK), being responsible for the phosphorylation of many secreted proteins, in addition to casein [6] [7] [8] . More recently, a phosphoproteomics analysis taking advantage of Fam20C null cells, while confirming the global role of this kinase to generate the phosphosecretome [9] , strongly supports the implication of Fam20C/G-CK in several human pathologies, not only related to biomineralization but also to altered phosphate and lipid homeostasis and to neoplasia [10, 11] .
Fam20C belongs to a small family of Four Jointed (FJ)-related proteins that show weak sequence and structural similarity to PI4KII [12] . These proteins were not included in the protein kinase complement of the human genome, the so called 'kinome' [13] . The two members of the family closest to Fam20C, Fam20B, and Fam20A, are not endowed with protein kinase activity: the former is responsible for the phosphorylation of xylose residues in the glycosaminoglycan-protein linkage region of proteoglycans [14] , while the latter, albeit devoid of kinase activity by itself, can associate with Fam20C and stimulate its protein kinase activity [15] . Fam20A, however, is unlikely to be an obligatory subunit/activator of Fam20C because it is not expressed in numerous cell lines where Fam20C is present (according to The Human Protein Atlas) and in mice [16] [17] [18] .
An alternative mechanism for controlling Fam20C/ G-CK activity may rely on sphingolipid signaling, as it has been observed that sphingosine stimulates Fam20C/G-CK activity both when assayed in the presence of Mn 2+ (i.e., optimal in vitro conditions) or, even more, in the presence of physiological concentrations of Mg
2+
, a condition where its activity is almost undetectable unless sphingosine is included in the reaction [19] . These data were obtained with recombinant Fam20C, assayed in vitro or upon transfection of HEK293T cells which have very low levels of Fam20C. In order to gain more reliable information about the physiological relevance of sphingolipid signaling on Fam20C kinase activity, we have investigated endogenous Fam20C/G-CK activity in three cell lines where the kinase is expressed under basal conditions, to check if its activity is altered upon depletion of sphingosine and/or perturbation of sphingolipids signaling. The outcome of our study provides the clear-cut demonstration that depletion of sphingosine from cells promotes the inactivation of Fam20C. Moreover, if sphingosine-depleted cells are supplemented with exogenous sphingosine and/or some of its analogs/precursors, Fam20C activity is restored.
Results

Variable responsiveness of recombinant Fam20C to sphingosine-related compounds
In the intricate network of sphingolipid metabolism, sphingosine is generated from ceramide through a deacylation reaction catalyzed by ceramidase (see Fig. 1A ). Both ceramide and sphingosine are signaling molecules, only the latter, however, is able to stimulate Fam20C both in the presence of Mn 2+ and, more dramatically, in the presence of Mg 2+ [19] . In order to gain information about the structural features determining Fam20C susceptibility to sphingosine, yet not to ceramide, a number of compounds structurally and/ or functionally related to sphingosine (on display in Fig. 1B ) have been assayed for their ability to affect Fam20C activity. The results are shown in Fig. 2 .
The data, while confirming the inability of ceramide to stimulate Fam20C activity, show that sphingosine-1-phosphate is poorly effective, N-acetyl-sphingosine is nearly ineffective, and the same applies to myriocin, a potent inhibitor of the first step of the cascade leading to the biosynthesis of sphingosine, widely used to deplete cells of this lipid [20, 21] . In contrast, sphingosine is able to stimulate Fam20C activity with a Kd around 11 lM, compatible with its physiological concentration in the low micromolar range [22] . Moreover, a number of sphingolipids display an activation of Fam20C comparable or even superior to that of sphingosine, either in the presence of Mn 2+ or Mg 2+ . To note in particular, L-erythro-sphingosine and phytosphingosine: stimulation by the latter is already maximal at 10 lM concentration and displays no subsequent decrease at higher concentrations as it happens with sphingosine and L-erythro-sphingosine. Phytosphingosine is not only particularly abundant in yeast and plants [23] but it is also present in animals [24, 25] .
From the data above it can be argued that the ability of sphingolipids to stimulate Fam20C activity critically depends on the availability of the amino group that in ceramide and in N-acetyl-sphingosine is lost to generate a carboamidic bond. To note that this amino group is also present in fingolimod (Fig. 1B) , an immunosuppressant drug shown to activate Fam20C in vitro [19] . On the other hand, the low in vitro efficacy of sphingosine-1-P may be due to its phosphate group or to poor solubility.
Since we have previously shown that the efficacy of sphingosine is partially due to a chaperone-like effect because it protects Fam20C from thermal inactivation, we wanted to check if the same applies to other analogs that display a stimulatory effect comparable to sphingosine. The results, reported in Fig. 3 , support such a conclusion by showing that, while the protective efficacy of sphingosine is lost with ceramide, it is still quite evident with phytosphingosine. It seems likely, therefore, that by binding to Fam20C, sphingosine and its active analogs confer to the kinase a conformation which is at the same time more stable and better shaped for catalysis.
Detection of Fam20C activity in human cell lines
Once established that in vitro Fam20C can be activated by sphingosine and other naturally occurring sphingolipids sharing similar structural features, we wanted to assess the physiological relevance of such an observation by monitoring endogenous Fam20C activity in cells under conditions where the level of sphingosine and possibly of other sphingolipids is altered. This would imply the availability of an assay highly specific and sensitive at the same time to allow the measurement of Fam20C activity in the lysates and/or the conditioned medium of cells not transfected with recombinant Fam20C. The first choice of substrate for this kind of assay is the b-casein-derived peptide b28-40 [6] , whose phosphorylation by kinases other that G-CK/Fam20C has never been reported so far.
We have exploited this peptide to detect Fam20C activity in the lysates and in the conditioned medium of three human cell lines, MDA-MB-231, U2OS, and HepG2. According to the Human Protein Atlas [16, 17] , all three cell lines do express Fam20C; although HepG2 cells also express Fam20A, another member of the Fam20 family devoid of kinase activity but capable to activate Fam20C [15] , the other two cell lines do not express significant amounts of Fam20A. As shown in Fig. 4A , the lysates of all these three cell lines display a comparable kinase activity toward the specific peptide substrate. Such an activity, as expected in the case of Fam20C, is unaffected by 0.1 mM staurosporine and is stimulated by 25 lM sphingosine. The proof of concept that the kinase activity detected with the aid of the specific peptide substrate is attributable to Fam20C was provided by comparing the data of the wild-type MDA-MB-231 cells with that of a clone where Fam20C has been knocked out by CRISPR/Cas methodology [11] . As shown in Fig. 4B , kinase activity Stimulatory compounds have been tested also at different concentrations (panels A and B). Experimental conditions are described in the Materials and methods section.
detected with the specific peptide in the lysate of the cells where Fam20C has been knocked out is negligible and not stimulated by sphingosine. Similar data were obtained using the conditioned medium where Fam20C is secreted, instead of the cell lysate: in this case, detection was less straightforward as it implies previous concentration of the conditioned medium. Significant activity was detected with WT MDA-MB-231 cells but not with the Fam20C null cells (Fig. 4C) .
To the best of our knowledge this is the first time endogenous Fam20C activity has been biochemically detected and quantified in the lysates of nontransfected cells. Furthermore, these experiments also demonstrate that the b28-40 peptide is a highly specific Fam20C substrate that can be used to efficiently monitor its kinase activity in cells.
Cell depletion of sphingosine promotes inactivation of endogenous Fam20C
Once demonstrated that endogenous Fam20C catalytic activity can be measured in cell lysates and conditioned medium with the aid of the specific peptide substrate, we wanted to check if and to what extent such an activity is dependent on endogenous sphingosine. To this aim we have depleted cells of sphingosine by treatment with myriocin, a potent inhibitor of serine palmitoyltransferase, the enzyme responsible for the first step of the pathway leading to the biosynthesis of sphingosine (see Fig. 1A ). As shown in Fig. 5 (Fig. 5B ) the residual activity observed in myriocin-treated (sphingosine depleted) cells could be significantly increased by addition of sphingosine to the reaction medium. A significant residual activity and responsiveness to sphingosine, however, could be restored if cells, during the depletion of endogenous sphingosine, were supplemented with exogenous sphingosine or with other sphingolipids, notably dihydrosphingosine and phytosphingosine, shown above to be potent activators of Fam20C. The recovery of activity promoted by these sphingolipids is quite evident either in the presence of Mn 2+ (Fig. 6A) or, even more in the presence of Mg 2+ (Fig. 6B) , the latter of which may represent more physiological conditions. The efficacy of dihydrosphingosine is of special interest because this compound, besides being effective by itself (see Fig. 2 ), also is a metabolic precursor of sphingosine, placed downstream from myriocin blockage (see Fig. 1A ). This observation prompted us to test another precursor of sphingosine, ceramide, also downstream from myriocin blockage but devoid of any intrinsic capability to directly activate recombinant Fam20C in vitro, for its ability to restore active endogenous Fam20C, if supplemented with cells during myriocin treatment. Indeed, as shown in Fig. 6C , ceramide is also able to restore significantly the level of active Fam20C in MDA-MB-231 sphingosinedepleted cells. All these data are consistent with a scenario, whereby in cells depleted of sphingosine by myriocin treatment the activity of endogenous Fam20C is lost, but it can be, at least partially, preserved and/or restored by supplementing cells with either sphingolipids capable to directly activate Fam20C or with sphingosine precursors that can generate sphingosine bypassing the myriocin blockage.
Finally it should be underscored that all the alterations highlighted in MDA-MB-231 cells upon variable treatments with myriocin and sphingolipids are attributable to endogenous Fam20C, as they disappear in MDA-MB-231 Fam20C KO cells (see Fig. 6A,B) .
The amount of Fam20C is not affected by cell treatment with myriocin
A crucial question raised by the experiments above is whether the oscillations of Fam20C activity observed under different conditions are due to changes in the level of endogenous enzyme or to a real regulation of its catalytic activity. To assess this point we have tested a number of commercially available Abs (see Materials and methods) for their ability to provide a reliable quantitation of endogenous Fam20C in the lysates and conditioned medium of our cells, where the kinase activity is measured. All our attempts, however, proved unsuccessful since the amount of endogenous Fam20C was too little for undergoing a reliable immunodetection with the Abs available. In contrast, this negative outcome highlights the sensitivity of the biochemical method based on the phosphorylation of the specific peptide, which instead is adequate to provide a reliable measurement of endogenous Fam20C catalytic activity.
To circumvent this inconvenience we have decided to transfect two cell lines used for our investigation (MDA-MB-231 and U2OS) with a C-terminal Flagtagged Fam20C construct, which is readily detected with remarkable sensitivity, and to repeat some of the critical experiments above under conditions where recombinant Fam20C can be quantified by immunoblotting. As shown in Fig. 7 , Fam20C activity in the lysates of transfected cells is, as expected, higher than in nontransfected cells and susceptible to stimulation by sphingosine. Both activity and responsiveness to sphingosine disappear in the lysates of transfected cells treated with myriocin, unless during myriocin treatment cells are supplemented with exogenous sphingosine or phyto-sphingosine (Fig. 7) , as shown above in the case of endogenous Fam20C (Fig. 6A,B) . In this case, however, the amount of recombinant Fam20C in the lysates could be precisely determined by immunoblotting with antiflag antibody and found not to undergo any significant change either upon addition of myriocin or of sphingosine and phyto-sphingosine (Fig. 7, inset) . We can conclude therefore that the observed changes in Fam20C activity reflect an intrinsic regulation of the kinase rather than of its amount/turnover. These results are also consistent with the fact that sphingosine and its analogs can activate recombinant Fam20C in vitro. 
Discussion
In the present report, evidence is presented for the first time that the activity of endogenous Fam20C, an atypical protein kinase responsible for the phosphorylation of casein and of a plethora of other secreted proteins, can be detected in the lysates and in the conditioned medium of three human cell lines and is under the control of sphingolipid signaling. Fam20C activity drops to negligible values if cells are treated with myriocin, a powerful inhibitor of serine palmitoyltransferase, that is, the first step of the sphingolipid cascade [20] . Myriocin treatment causes the depletion of sphingosine and other sphingolipids downstream of the serine palmotoyl-transferase reaction [21] . Based on our data, sphingosine appears to be the first choice candidate for acting as the main physiological regulator of endogenous Fam20C: First, sphingosine is a potent activator of recombinant Fam20C in vitro, displaying a Kd around 11 lM, which is compatible with the physiological concentration of this sphingolipid, normally in the low micromolar range [22] ; second, and more importantly, the immediate precursor of sphingosine, ceramide, is unable to activate Fam20C by itself but it can partially restore its activity if supplemented with cells treated with myriocin, whose blockage is upstream from the ceramide to sphingosine conversion step (see Fig. 1 ). The reduced efficacy of ceramide as compared to sphingosine may reflect two concomitant circumstances: an only partial conversion of ceramide into its active derivatives, and differences in permeability between ceramide and sphingosine. In general, issues related to cell permeability are likely responsible for the significantly different efficacy of individual sphingolipids depending on whether they are assayed in vitro (Fig. 3A) or in a cell system (Fig. 6A) . It is still possible that in addition to sphingosine, other sphingolipids whose level is reduced by myriocin might cooperate in the activation of Fam20C: this especially applies to phytosphingosine and to L-erythro-sphingosine, both of which display an in vitro stimulatory activity comparable to that of sphingosine. Another intriguing possibility would be the implication of sphingosine-1 phosphate (S1P) a pleiotropic second messenger generated from sphingosine by two distinct sphingosine kinases (SPK1 and SPK2). In general cellular S1P is more abundant than sphingosine (especially in cancer cells) and it also decreases in response to myriocin [26] . In our hands, however, S1P proved a poor in vitro activator of recombinant Fam20C [19] as compared to sphingosine and it fails to restore the activity of endogenous Fam20C in myriocin-treated cells, at variance with sphingosine and its active analogs (see Fig. 6 ).
An interesting issue raised by the dependence of Fam20C activity on sphingolipid signaling is its possible relatedness with another mode of Fam20C activation, provided by interaction with Fam20A, a closely related protein, devoid, however, of intrinsic kinase activity [15] . Both sphingosine (and other sphingolipids as well) and Fam20A are able to stimulate many-fold Fam20C activity. It should be noted, however, that while sphingolipids provide a general mechanism of activation, which in principle operates in any kind of cell, this may not be the case with Fam20A whose expression in mice is restricted to ameloblasts, odontoblasts, the parathyroid gland, and renal tubules of the kidney [18, 27] , whereas Fam20C expression is more widespread. In particular Fam20A is expressed only in one of the cell lines used in our study, HepG2, while it is lacking in the other two, MDA-MB-231 and U20S. All three display comparable level of Fam20C activity and comparable responsiveness to both sphingosine stimulation and myriocin blockage, an observation that argues against the hypothesis that susceptibility to sphingolipids is altered by the presence of Fam20A. It should be noted, however, that in order to fully display its stimulatory efficacy, Fam20A must be added to Fam20C in a 10-20-fold molar excess [15] .
Given the implications of Fam20C in bone disorders (osteosclerosis, severe dental demineralization disease, Raine syndrome), a pertinent question would be whether a connection exists between sphingolipid metabolism and biomineralization pathologies, which could be related to alterations in Fam20C activity. Interestingly sphingosine derivatives have been recently linked to biomineralization, in particular enhancing osteogenic differentiation [28] ; moreover, sphingosine, phytosphingosine, and sphinganine protect teeth from acid-induced demineralization [29] . In the light of our results, it is tempting to speculate the implication of Fam20C in this phenomenon. From a practical standpoint the well-documented implication of Fam20C in hypophosphatemia [30] may deserve attention, especially considering that fingolimod, a sphingomimetic immunosuppressive drug also approved for the treatment of multiple sclerosis [31] , is among those compounds that are able not only to stimulate Fam20C activity in vitro [19] but also to recover Fam20C activity if supplemented with myriocin-treated, sphingosinedepleted cells (see Fig. 6A ). This observation in conjunction with the finding that fingolimod activates a Fam20C loss of function mutant (T268M) responsible for disorders of phosphate homeostasis caused by alterations in serum FGF23 levels [19] , discloses the possibility that fingolimod and its derivatives can afford a therapeutic aid to treat pathologies caused by hypophosphatemia.
The mechanism by which sphingolipids activate Fam20C is only partially understood. Kinetics with recombinant Fam20C show that sphingosine displays its favorable effect by both decreasing the Km (ATP) and increasing the Vmax, this latter effect being dramatic if Mn 2+ is replaced by Mg 2+ as a cofactor in the kinase reaction [19] . This demonstrates that in the presence of sphingosine, the conformation of the active site is altered in such a way that catalysis becomes much more proficient (> 155-fold increase in the K cat /K m ratio [19] ). On the other hand sphingolipids also protect Fam20C against thermal denaturation ( [19] and this paper) raising the question whether the two effects, on catalysis and stability, are related (i.e., promoted by the same conformational alteration(s)) or are independent of each other. The former explanation appears more likely considering that different sphingolipids are equally effective in catalysis and stability (compare Figs 2 and 3) . Based on these observations we reasoned that the drop of Fam20C activity promoted by depleting cells of sphingolipids with myriocin might be due at least partially to higher instability and faster degradation of the kinase. This, however, seems not to be the case as the disappearance of Fam20C activity promoted by cell treatment with myriocin does not parallel any significant decrease in ectopically expressed Fam20C protein (see Fig. 7 ). We have to assume therefore that Fam20C synthesized in sphingolipid-depleted cells acquires an inactive conformation which cannot be reversed anymore upon addition of sphingosine. If however, sphingosine or other active sphingolipids are supplemented to the depleted cells, they can prevent such an irreversible inactivation giving rise to an active form of Fam20C which can be further activated if the competent sphingolipids are added to the kinase assay medium. It seems likely therefore that sphingolipids play a key role at two stages: to ensure an active conformation to newly synthesized Fam20C molecules, and to confer to these a higher catalytic efficiency. According to our data, the latter effect is reversible, while the former is not, since Fam20C in the lysates and conditioned medium of myriocintreated cells (not supplemented with exogenous sphingolipids) is not only nearly inactive but also refractory to sphingosine stimulation (see Figs 4 and 5) . Whether this implies two distinct binding sites for sphingolipids on the Fam20C molecule is presently unknown.
Attempts to map such site(s) exploiting the 3D structure of Caenorhabditis elegans Fam20C are challenged by the observation that this particular form of Fam20C is not susceptible to sphingosine stimulation (V. S. Tagliabracci, unpublished data). Additional work will be required in order to unravel at molecular level the structural features underlying this complex mode of regulation. Critical steps to this aim will be the mapping of the interactions between Fam20C and sphingolipids and the solution of the structure of Fam20C bound to sphingosine.
Materials and methods
Materials
Ceramide, sphingosine, sphingosine-1-phosphate, dihydrosphingosine, L-erythro-sphingosine, phytosphingosine, Nacetyl-sphingosine, fingolimod, myriocin, and staurosporine were purchased from SIGMA and dissolved in DMSO 100%; The synthetic peptide substrate b(28-40), KKIEKFQ-SEEQQQ [6] was synthetized by CRIBI Peptide Facility, University of Padova. Recombinant Fam20C-SUMO was purified as described in [2] . Anti-Fam20C antibodies (ab154740, ab107079, ab81128) were purchased from Abcam. Monoclonal anti-FLAG (clone M2), antibody was purchased from SIGMA. Fam20C-FLAG, was described in [2] . Fam20C KO MDA-MB-231 cells were described in [11] .
In vitro kinase assays ), and the synthetic peptide substrate KKIEKFQSEEQQQ (b28-40) (400 lM, unless differently indicated). After 10 min of incubation at 37°C, the reaction was stopped by addition of 5 lL of 0.5 M orthophosphoric acid before spotting 20-lL aliquots on to phosphocellulose filters. Filters were washed in 75 mM phosphoric acid (5-10 mL each) four times then once in methanol and dried before counting with PerkinElmer TriCarb 2810 TR. Fam20C activity is expressed in U, one unit (U) being defined as the amount of Fam20C that catalyzes the incorporation of 1 pmol phosphateÁmin À1 into the peptide substrate. Sphingosine and derivatives were initially assayed at different concentration up to 100 lM and then compared at a fix concentration (25 lM). K d for sphingosine was calculated through the following equation for competitive activation [32] : Cell culture, treatments and transfection U2OS, HepG2, and MDA-MB-231 cells were maintained in 5% CO 2 in DMEM supplemented with 10% FBS, 2 mM L-glutamine, 100 UÁmL À1 penicillin, and 100 mM streptomycin, in an atmosphere containing 5% CO 2 .
Cell treatments were performed in six-well plates at about 70-80% confluence in a complete medium. Control cells were treated with equal amounts of DMSO. For the collection of conditioned medium, plated cells were washed three times with PBS and incubated with a serum free medium before treatment.
For transfection, cells were plated onto six-well dishes in complete medium at about 40-50% confluence. The day after, cells were transiently transfected for 48 h using Lipofectamine 3000 (Life Technologies Italia, Monza, Italy) according to the manufacturer's instructions.
Cells were treated with different compounds at 10 lM concentration, and with myriocine at 1 lM. All these concentrations have been demonstrated to be safe for cell vitality.
Cell lysis, conditioned medium collection, and western blotting Cells were detached, centrifuged, extensively washed with PBS, and lysed by the addition of ice-cold buffer containing 20 mM Tris-HCl (pH 8), 150 mM NaCl, 1 mM EGTA, 1% Triton X-100 (v/v), protease inhibitor cocktail Complete (Roche Diagnostics, Mannheim, Germany). After 20 min of incubation in ice, the lysate was centrifuged 10 min at 10 000 g at 4°C. The supernatant was collected and protein concentration was determined by the Bradford method. When required, equal amounts of proteins were separated by SDS/ PAGE (11% gels), blotted on Immobilon-P membranes, processed by WB (western blotting) with the indicated antibody, and detected by chemiluminescence on a Kodak Image Station 440MM PRO.
For the collection of conditioned medium, after cell treatments, conditioned medium (without serum) was collected and centrifuged twice, 5 min at 700 g and then 5 min at 16 000 g. Supernatant was concentrated ten times using vivaspin (cut-off 5 kDa, Sartorius) and protein concentration was determined by the Bradford method.
Kinase activity determinations in cell lysate and conditioned medium
All the lysate assays were performed as described above for in vitro assay, with 5 mM MnCl 2 or MgCl 2 and in the absence and presence of 25 lM sphingosine, and 400 lM b
